PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Channel PR

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Rajiv Gandhi Cancer Institute & Research Center Brings New Technology in Cancer Management to India - Star Health Network, Inc. (Star) and Rajiv Gandhi Cancer Institute & Research Center (RGCI&RC) are proud to announce the availability of molecular Tumor Profiling (TP) tests from the Yale School of Medicine and Thomas Jefferson University, USA
Rajiv Gandhi Cancer Institute & Research Center Brings New Technology in Cancer Management to India

 

NewswireToday - /newswire/ - New Delhi, Delhi, India, 2013/12/02 - Star Health Network, Inc. (Star) and Rajiv Gandhi Cancer Institute & Research Center (RGCI&RC) are proud to announce the availability of molecular Tumor Profiling (TP) tests from the Yale School of Medicine and Thomas Jefferson University, USA.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

RGCI&RC is the first Indian cancer hospital to offer this new cancer detection technology, which provides the genomic information on a patient's tumor and advances the delivery of high quality of personalized precision medicine. Precision Medicine is the tailoring of medical treatment according to the unique genetic profile of each patient's tumor.

Tumor profiling help search out that genetic alteration which is driving the growth of tumor and can possibly be targeted with the available targeted molecule or by molecules in clinical trials and pipeline. TP tests are currently available for Lung, Breast, Biliary Tract (Pancreas, Bile Duct, Gallbladder) Ovarian, Thyroid, Colorectal & Urinary Tract cancers and Acute Leukemia & Melanoma. TP tests are tailored from eight genes most likely to be altered in these common cancers. TP tests detect 69 actionable mutations, meaning there are approved drugs or drugs in clinical trials that can target these specific mutations.

For Indian cancer patients the process is simple: world-class pathologists at Yale School of Medicine & Thomas Jefferson University perform high throughput genotyping analysis of a patient's tumor DNA and provide a report within 10-15 days. Oncologists at RGCI&RC or your center can then match the genomic profile of your tumor to available drugs or drugs in clinical trials. This personalized approach of targeted therapy could result in many more patients receiving only those drugs that are known to work specifically for their kind of cancer. "Having a targeted therapy to a cancer mutation can reduce the need for chemotherapy, which is associated with debilitating side effects," said Dr. John Sanil Manavalan, Chief Medical Officer of Star.

Dr. Mehta, Chief of Pathology at RGCI&RC, recently visited Yale and Thomas Jefferson University and other Star partner institutions in the United States, to obtain first hand exposure to this unique TP technology. He says,"This is a beginning of a revolution and is a big step in advancing precision medicine in cancer. We have launched a national awareness campaign to help physicians and patients understand how TP tests can be effective in cancer care. This is the result of our partnership with leaders like Star, and its network of U.S. institutions, in all areas of clinical oncology and cancer genomics; partners who are equally committed to the changing the paradigm of cancer care".

"Overall, cancer genetic profiling is revolutionizing the way cancers are treated. Star and its U.S. institutional partners are the first to bring this cutting edge technology to India with RGCI&RC as its partner. All patients who have cancer or have been recently diagnosed with cancer should consult their treating oncologists to take advantage of the availability of these tests at RGCI&RC," said Dr. Jamal Naiyer, President and CEO of Star.

Mr. David McCallen spokesperson and Chief Marketing Officer of Star provides a high level analysis: "While India has made tremendous progress in healthcare delivery over the past decade, it is still behind in leading edge diagnostics and research. Our priority is to bridge these gaps by providing access to world-class healthcare institutions and their innovations: these tests from the Yale School of Medicine are a perfect, real world example of how our network can positively impact patients, doctors and hospitals worldwide.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Channel PR

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Rajiv Gandhi Cancer Institute & Research Center Brings New Technology in Cancer Management to India

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Prasoon - ChannelPR.in 
+91 98 71744743 info[.]channelpr.in
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Channel PR securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Channel PR / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)